SunTrust Robinson Sticks to Their Hold Rating for Tenet Healthcare

By Austin Angelo

SunTrust Robinson analyst David S Macdonald reiterated a Hold rating on Tenet Healthcare (NYSE: THC) today and set a price target of $27. The company’s shares closed yesterday at $24.03, close to its 52-week high of $25.24.

According to, Macdonald is a 4-star analyst with an average return of 8.4% and a 65.1% success rate. Macdonald covers the Services sector, focusing on stocks such as American Renal Associates Holdings Inc, Encompass Health Corporation, and Walgreens Boots Alliance.

Tenet Healthcare has an analyst consensus of Moderate Buy, with a price target consensus of $25.11.

The company has a one-year high of $25.24 and a one-year low of $12.25. Currently, Tenet Healthcare has an average volume of 2.42M.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.

Tenet Healthcare Corp. engages in the provision of health care services. Through its subsidiaries and affiliates, it owns and facilitates acute care hospitals, ambulatory surgery centers, diagnostic imaging centers, and related health care facilities.